OptimizeRx Corp - FORM 10-K - EX-10.4 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH WILLIAM FEBBO, DATED MARCH, 10, 2020 - March 26, 2020

Attached files

file filename
10-K - ANNUAL REPORT - OptimizeRx Corpf10k2019_optimizerxcorp.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO - OptimizeRx Corpf10k2019ex32-1_optimizerx.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-2_optimizerx.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-1_optimizerx.htm
EX-23.1 - CONSENT OF MARCUM LLP - OptimizeRx Corpf10k2019ex23-1_optimizerx.htm
EX-21.1 - LIST OF SUBSIDIARIES - OptimizeRx Corpf10k2019ex21-1_optimizerx.htm
EX-10.6 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH MIRIAM PARAMORE, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-6_optimizerx.htm
EX-10.5 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH STEPHEN SILVESTRO, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-5_optimizerx.htm
EX-10.3 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH DOUG BAKER, DATED MARCH 10, 2020 - OptimizeRx Corpf10k2019ex10-3_optimizerx.htm

Exhibit 10.4

 

Employment Agreement Addendum I

Addendum to agreement dated September 10, 2018

 

This first addendum to the employment agreement (the “Addendum”) is made this 10th day of March 2020, by and between OptimizeRx, Corporation (the “Company”), a Nevada Company, and William Febbo (the “Executive”).

 

Base Salary: The Executive will receive a base salary at the annualized rate of $350,000.00 (“Base Salary”), for 2020 and $400,000.00 for 2021 calendar year, which will be paid in accordance with normal Company payroll practices and subject to the usual and applicable required withholding(s).

 

Effective Date: January 1, 2020 & January 1, 2021

 

Acknowledgment:

 

Except as expressly set forth herein, all other terms of the Agreement remain in full force and effect.

 

OptimizeRx, Corporation   William Febbo
         
By: Douglas P. Baker   By: William Febbo
Its: Chief Financial Officer   Date: March 10, 2020
Date:  March 10, 2020      

 

 

 

Stock widget

Investing forum

OptimizeRx Corp Reports